Nuvation Bio Inc.
NUVB
$2.88
-$0.02-0.69%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 236.79% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 236.79% | -- | -- | -- | -- |
| Cost of Revenue | 91.24% | -- | -- | -- | -- |
| Gross Profit | 2,464.77% | -- | -- | -- | -- |
| SG&A Expenses | 138.20% | 381.08% | 376.97% | 151.76% | 114.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -85.50% | 207.38% | 186.37% | 85.38% | 1,705.59% |
| Operating Income | 86.48% | -192.11% | -158.95% | -82.62% | -1,700.10% |
| Income Before Tax | 87.24% | -259.90% | -258.63% | -109.73% | -2,140.76% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 87.24% | -259.90% | -258.63% | -109.73% | -2,140.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 87.24% | -259.90% | -258.63% | -109.73% | -2,140.76% |
| EBIT | 86.48% | -192.11% | -158.95% | -82.62% | -1,700.10% |
| EBITDA | 86.55% | -191.42% | -158.58% | -82.39% | -1,703.03% |
| EPS Basic | 90.83% | -132.89% | -132.86% | -67.89% | -1,903.92% |
| Normalized Basic EPS | 90.84% | -132.94% | -132.15% | -67.74% | -1,912.10% |
| EPS Diluted | 90.83% | -128.57% | -132.86% | -67.89% | -1,903.92% |
| Normalized Diluted EPS | 90.84% | -132.94% | -132.15% | -67.74% | -1,912.10% |
| Average Basic Shares Outstanding | 39.23% | 54.58% | 53.86% | 24.95% | 11.83% |
| Average Diluted Shares Outstanding | 39.23% | 54.58% | 53.86% | 24.95% | 11.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |